期刊文献+

荧光原位杂交在多发性骨髓瘤中的应用 被引量:2

Application of fluorescence in-situ hybridization technique in multiple myeloma
暂未订购
导出
摘要 目的:探讨我国多发性骨髓瘤(multiple myloma,MM)常见的染色体异常及其与各项血清学指标和疗效的关系,旨在筛选有效预测疾病预后的指标,为个体化治疗提供依据。方法:运用荧光原位杂交技术(fluorescence in situ hybridization,FISH)对31例MM患者进行del(13q)、14q32易位、del(17p13)、1q21扩增等细胞遗传学异常检测,其中del(13q)的检测采用了D13S319、RB1两种探针,14q32易位的检测采用IgH探针,del(17p13)的检测采用P53探针,1q21扩增的检测采用1q21探针。分析细胞遗传学异常与患者临床特征、疗效之间的相关性。结果:MM患者13号染色体缺失、14q32易位、1q21异常、17p13缺失的检出率分别为45%、68%、50%、35%;35%的患者同时检出13号染色体部分缺失和14q32易位,79%del(13q)者伴有14q32易位,其中D13S319探针检测阳性者100%伴有14q32易位。31例MM患者诱导治疗后有21例患者达到了轻微反应(欧洲血液和骨髓移植协作组EBMT疗效标准)以上的疗效,总反应率为67.7%,未发现del(13q)、14q32易位、del(17p13)和1q21扩增阳性患者与细胞遗传学异常阴性患者在总反应率上存在差异。结论:国人MM患者的常见染色体异常是del(13q)、14q32相关的易位、1q21异常、del(17p13),其中del(13q)与14q32相关的易位具有密切相关性。 Objective: To investigate with multiple myeloma in China and th features. Methods: In interphase fluore the common chromosome abnormalities of the patients e relationships of cytogenetic abnormalities and cli scence in-situ hybridization (FISH) analysis,a pan probes including D13S319 (13q14. 3),RBI(RB1 gene),IgH (14q32),P53(17p13),1q21( gene) was used to study the cytogenetic abnormalities of 31 patients with multiple myeloma; the cli of the in 1q2 nical el of 1q21 and nical implications of cytogenetic abnormalities were investigated. Results: The frequencies partial deletion of chromosome 13,translocation involving the 14q32 region,abnormalities 1 and deletion of 17p13 were 45%, 68%, 50%,and 35% in the study, respectively. The abnormalities of both the partial deletion of chromosome 13 and translocation involving the 14q32 region were found in 35% of the patients. 79% of the patients with del (13q) had 14q32 translocations simultaneously. All the patients with positive detection of probe D13S319 were found to have translocation of 14q32 at the same time. There were correlations between the partial deletion of chromosome 13 and translocation involving the 14q32 region. The overall response rate of induction treatment was 67.7 %. No significant difference was found in patients with positive or negative cytogenetic abnormalities of del (13q), 14q32 translocation, del (17p13), and lq21 abnormalities. Conclusions: 13q deletion, IgH rearrangement, chromosome 1 abnormality and 17p13 deletion are the common cytogenetic abnormalities of MM patients in China. There is a significant correlation between the presence of 14q32 translocations and chromosome 13 deletion in MM patients.
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2009年第5期459-464,共6页 Journal of Zhejiang University(Medical Sciences)
关键词 多发性骨髓瘤/遗传学 原位杂交 荧光 细胞遗传学 染色体畸变 预后 Multiple myeloma/genet In situ hybridization, fluorescence Cytogenetics Chromosome aberrations Prognosis
  • 相关文献

参考文献15

  • 1GREIPP P R,SAN M J,DURIE B G,et al.International staging system for multiple myeloma[J].J Clin Oncol,2005,23(15):3412-3420.
  • 2SAWYER J R,WALDRON J A,JAGANNATH S et al.Cytogenetic findings in 200 patients with multiple myeloma[J].Cancer Genet Cytogen,1995,82:41-49.
  • 3NISHIDA K,TAMURA A,NAKAZAWA N et al.The Ig heavy chain is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization[J].Blood,1997,90:526-534.
  • 4张之南,沈悌.Criterion of Diagnosis and Cure in Hematology(血液病诊断及治疗标准)[M].3nd Edition.Beijing:Science Press,2007,232-235.
  • 5BLADE J,SAMSOND,REECE D,et al.Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high dose therapy and hemopoietic stem cell transplantation.Myeloma subcommittee of the EMBT.European Group for Blood and Marrow Transplant[J].Br J Haematol,1998,102(5):1115-1123.
  • 6CARRASCO D R,TONON G,HUANG Y,et al.High-resolution genomic profiles define distinct clinico-patho-genetic subgroups of multiple myeloma patients[J].Cancer Cell,2006,9:313-325.
  • 7AVET-LOISEAU H,FACON T,GROSBOIS B,et al.Oncogenesis of multiple myeloma:14q32 and 13q chromosomal abnormalities are not randomly distributed,but correlate with natural history,immunological features,and clinical presentation[J].Blood,2002,99(6):2185-2191.
  • 8FONSECA R,BARLOGIE B,BATAILLE R,et al.Genetics and cytogenetics of multiple myeloma:a workshop report[J].Cancer Res,2004,64(4):1546-1558.
  • 9CHANG H,QI C,YI Q L,et al.p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation[J].Blood,2005,105(1):358-360.
  • 10GUTI RREZ N C,HERN NDEZ J M,GARC A J L,et al.Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma:monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells[J].Haematologica,2000,85(11):1146-1152.

同被引文献20

  • 1魏道林,秦尤文,王椿,颜式可,高彦荣,蔡琦.多发性骨髓瘤患者13号染色体长臂部分缺失及其临床意义[J].中华内科杂志,2006,45(3):217-220. 被引量:3
  • 2Fonseca R,Oken M M, Harrington D,et al. Deletions of chromosome la in multiple myeloma identified by inter- phase FISH usually denote large deletions of the qarm or monosomy[J].Leukemia, 2001,15 (6) : 981.
  • 3Sawyer JR, Waldron JA, Jagannath S, et al. Cytogenetic /indings in 200 patients with multiple myeloma[J].Cancer Genet Cytogen, 1995,82 ( 1 ) : 41-49.
  • 4江涛.荧光原位杂交检测多发性骨髓瘤分子细胞遗传学异常的研究[D].吉林:吉林大学,2009.
  • 5Yuregir J,Sahin FI, Yilmaz Z, et al. Fluorescent in situ hybridization studies in multiple myeloma[J]. Hematolo- gy, 2009,14(2) : 90-94.
  • 6Lee JW, Lee JK, Hong YJ, et al. Correlation of chromo- somal aberrations with prognostic markers in multiple myeloma patients-a single institution study[J]. Korean J Lab Med,2008,28(6) :413-418.
  • 7Takimoto M, Ogawa K, Kato Y, et al. Close relation be- tween 14q32/IGH translocations and chromosome 13 ab normalities in multiple myeloma: a high incidence of 11q13/CCND1 and 16q23/MAF[J]. Int J Hematol, 2008,87(3):260-265.
  • 8Wu KL, Beverloo B,Velthuizen SJ,et al. Sequential anal- ysis of chromosome aberrations in multiple myeloma dur ing disease progression [J]. Clin Lymphoma Myeloma, 2007,7 (4) : 280-285.
  • 9解菊芬,周永安,苏丽萍,王恺,赵瑾,马莉,石磊.17例多发性骨髓瘤患者13号染色体缺失的检测[J].中国现代医生,2009,47(11):7-8. 被引量:1
  • 10罗赛群,胡维新.1号染色体长臂扩增与多发性骨髓瘤[J].生命的化学,2009,29(6):830-833. 被引量:1

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部